Revolution Medicines Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Revolution Medicines Inc
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Frequently asked questions
To buy Revolution Medicines Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Revolution Medicines Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Revolution Medicines Inc is RVMD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Revolution Medicines Inc has its primary listing on NASDAQ. You can trade Revolution Medicines Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Revolution Medicines Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Revolution Medicines Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Revolution Medicines Inc.